What you must know about Innova Captab IPO?
by 5paisa Research Team
18 Dec 2023
Listing Details
- Listing Exchange BSE, NSE
- Listing Date 29-Dec-23
- IPO Price Range ₹426
- Listing Price ₹456.1
- Listing Change 1.8 %
- Last Traded Price ₹967.1
- Current Change 115.9 %
Innova Captab IPO Details
- Open Date 21-Dec-23
- Close Date 26-Dec-23
- Lot Size 33
- IPO Size ₹ 570 Cr
- IPO Price Range ₹ 426 to ₹ 448
- Min Investment ₹ 14,058
- Listing Exchange BSE, NSE
- Basis of Allotment 27-Dec-23
- Refunds 28-Dec-23
- Credit to Demat Account 28-Dec-23
- Listing Date 29-Dec-23
Innova Captab IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 21-Dec-23 | 0.44 | 1.00 | 2.25 | 1.47 |
| 22-Dec-23 | 1.08 | 3.38 | 5.20 | 3.63 |
| 26-Dec-23 | 116.15 | 66.83 | 17.64 | 56.33 |
Innova Captab IPO Synopsis
Innova Captab Limited IPO is all set to open from 21st December to 26th December 2023. It operates as an integrated pharmaceutical company. The IPO includes a fresh issue worth 320 cr and an Offer-for-Sale (OFS) of 5,580,357 shares worth ₹250 cr. The total IPO size is ₹570 cr. The share allotment date is 27th December, and the IPO will be listed on 29th December on the stock exchanges. The price band is ₹426 to ₹448 per share and the lot size is 33 shares.
ICICI Securities Limited and JM Financial Limited are the book-running lead managers for this IPO, while KFin Technologies Limited is the registrar.
Objectives of Innova Captab IPO:
● To fund working capital requirements.
● To invest in its subsidiary UML.
● To prepay or repay full/partial borrowings obtained by the company and its subsidiary UML.
● General corporate purpose.
Innova Captab IPO Video:
About Innova Captab
Established in 2005, Innova Captab Limited operates as an integrated pharmaceutical company. It has a comprehensive value chain for pharma products which includes research and development, manufacturing, drug distribution and marketing and exports.
The company has three major business categories:
● Contract development and manufacturing organization (CDMO): Offers manufacturing facility to Indian pharma companies
● Domestic branded generics business
● International branded generics business.
As of FY23 and for the June quarter ending in June 2023, the company has produced a portfolio of 600+ diverse generics products. Additionally, the company has a network of around 5,000+ distributors and stockists and 150,000+ retail pharmacies. For the same period, Innova Captab has also exported its branded generic products to 20 countries and 16 countries respectively.
Innova Captab has two manufacturing units based in Baddi, Himachal Pradesh. Some of the popular clients of Innova Captab include Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, and Intas Pharmaceuticals Limited.
Peer Comparison
● Ajanta Pharma Limited
● Torrent Pharmaceuticals Limited
● Laurus Labs Limited
● J. B. Chemicals and Pharmaceuticals Limited
● NATCO Pharma Limited
● Eris Lifesciences Limited
● Indoco Remedies Limited
● Suven Pharmaceuticals Limited
● Windlas Biotech Limited
For More Information:
Innova Captab IPO GMP
Webstory on Innova Captab IPO
Know About Innova Captab IPO
Innova Captab Financial Status
Profit and Loss
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 926.38 | 800.52 | 410.66 |
| EBITDA | 122.84 | 98.90 | 55.85 |
| PAT | 67.95 | 63.95 | 34.50 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Total Assets | 704.41 | 575.47 | 369.61 |
| Share Capital | 48.00 | 12.00 | 12.00 |
| Total Borrowings | 427.90 | 366.86 | 224.79 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | 67.12 | 58.90 | 41.57 |
| Net cash from / (used in) investing activities | -90.84 | -188.11 | -19.66 |
| Net cash flow from / (used in) financing activities | 27.09 | 124.57 | -19.33 |
| Net increase (decrease) in cash and cash equivalents | 3.37 | -4.64 | 2.56 |
Innova Captab IPO Key Points
-
Strengths
1. The company has a leading presence and is one of the fastest-growing CDMOs in the Indian pharmaceutical formulations market.
2. It has well-established relationships with its marquee CDMO customer base.
3. Its options are highly efficient, including its world-class manufacturing facilities and supply chain.
4. The company is focused on rapidly growing domestic and international export branded generics businesses.
5. Strong R&D focus to build an increasingly complex product portfolio and attract and retain customers.
6. Consistent financial performance is a big plus.
7. Experienced promoters and management team.
-
Risks
1. Operates in a highly competitive market.
2. It has substantial working capital requirements and working capital expenditure.
3. The company is dependent on China, China SEZ and Hong Kong for raw material supplies, exposing it to political, economic and social conditions in greater China.
4. Any reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing can impact the business.
5. The pharmaceutical market is subject to extensive regulation.
6. The company has a dependency on distributors and stockists for the sale and distribution of products.
7. Faces foreign exchange risks.
Innova Captab
How to apply for IPO?
-
Login to your 5paisa account and select the issue in the
current IPO section -
Enter the number of lots and price at which you wish to
apply for -
Enter your UPI ID and click on submit. With this, your
bid will be placed with the exchange -
You will receive a mandate notification to block funds in
your UPI app -
Approve the mandate request on your UPI and funds
will be blocked
Open account in 5 minutes
Be a part of the 5paisa community now with 10 million mobile app users
There is some issue, try later
By Proceeding, you agree T&C*
Innova Captab IPO FAQs
What is the minimum lot size and investment required for the Innova Captab IPO?
The minimum lot size of Innova Captab IPO is 33 shares and the investment required is ₹14,058.
What is the price band of Innova Captab IPO?
The price band of Innova Captab IPO is ₹426 to ₹448 per share.
When does the Innova Captab IPO opens and closes?
The Innova Captab IPO is open from 21st December to 26th December 2023.
What is the size of the Innova Captab IPO?
The size of Innova Captab IPO is around ₹570 cr.
What is the allotment date of the Innova Captab IPO?
The share allotment date of Innova Captab IPO is 27th of December 2023.
What is the Innova Captab IPO listing date?
The Innova Captab IPO will be listed on 29th of December 2023.
Who are the book runners for the Innova Captab IPO?
ICICI Securities Limited and JM Financial Limited are the book-running lead managers for Innova Captab IPO.
What is the objective of Innova Captab IPO?
The proceeds from this public issue will be used for:
● To fund working capital requirements.
● To invest in its subsidiary UML.
● To prepay or repay full/partial borrowings obtained by the company and its subsidiary UML.
● General corporate purpose.
How to apply for the Innova Captab IPO?
To apply for Innova Captab IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Innova Captab IPO
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
● You will receive a mandate notification to block funds in your UPI app.
Contact Details of Innova Captab IPO
Contact Information
Innova Captab Limited
601, Proxima,
Plot No. 19, Sector
30 A, Vashi, Navi Mumbai, 400 705
Phone: +91 22 2564 2095
Email: investors@innovacaptab.com
Website: https://www.innovacaptab.com/
Innova Captab IPO Register
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: innovacaptab.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Innova Captab IPO Lead Manager
JM Financial Limited
ICICI Securities Limited
IPO Related Articles
